AUROBINDO PHARMA
|
The Current P/S Ratio of AUROBINDO PHARMA is 2.72.
| Share Price | ₹1,653.3 | Sep 04,2026 |
| Market Cap | ₹95,130.9 Cr | |
| Sales-TTM | ₹34,935.3 Cr | TTM-Consolidated Results |
| Price/Sales | 2.72x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of AUROBINDO PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹95,130.9 Cr] as on Sep 04,2026
(/) Sales [ ₹34,935.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.72x ]
Thus, for AUROBINDO PHARMA , the investors are currently willing to pay '2.72 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of AUROBINDO PHARMA !
The chart below summarizes the trend in P/S Ratio of AUROBINDO PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of AUROBINDO PHARMA
PS Ratio Performance Analysis for AUROBINDO PHARMA
- AUROBINDO PHARMA 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 1.89x.
- AUROBINDO PHARMA 's operated at median p/e ratio of 2.12x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AUROBINDO PHARMA 's p/e ratio peaked in Mar2026 at 2.25x.
- AUROBINDO PHARMA 's p/e ratio hit its five-year low in Mar2023 of 1.22x.
How does AUROBINDO PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| AUROBINDO PHARMA | 34,935.3 | 2.72 | 95,130.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.61 | 455,634.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 21.51 | 241,576.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.73 | 184,478.0 |
| CIPLA LTD | 28,324.4 | 3.95 | 111,888.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.90 | 96,322.1 |
| MANKIND PHARMA LTD | 14,737.9 | 6.53 | 96,179.6 |
| LUPIN LTD | 29,966.6 | 3.22 | 96,528.8 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.91 | 111,820.0 |
| LAURUS LABS LTD | 7,269.6 | 13.68 | 99,417.5 |
| BIOCON LTD | 17,321.1 | 3.74 | 64,739.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AUROBINDO PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.72x |
| Max industry PS | 21.51x |
| Median industry PS | 3.95x |
| Average industry PS | 7.41x |
You may also like the below Video Courses